The Kaplan-Meier analysis showed that in 3 cancer types—ACC, p =0.009; COAD, p =0.014; and KIRC, p <0.001)—high ASB16-AS1 expression was associated with worse OS; in the other 3 cancers—BLCA, p =0.003; mesothelioma (MESO), p =0.040; and PAAD, p =0.043—high ASB16-AS1 expression represented better OS. Here, ASB16 is linked to pancreatic adenocarcinoma.